Generate Biomedicines, Inc.

NASDAQ:GENB

Asset Management

Financial Services
$10.38 +0.91%

+$0.13 today

Market cap
$1.34B
Beta
0.19
P/E (TTM)
-3.5
EPS (TTM)
-$4.06
52W Low $11.00High $16.75

Volume 1.05M

Average 0.55M

GENB Total Non-current Assets

All assets not expected to be converted to cash within one year.

Generate Biomedicines, Inc.NASDAQ: GENB

Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Total non-current assets of $90.35M in Q1 FY2026

Q1 FY2026 total non-current assets was $90.35M.

Context

  • Total non-current assets amounted to 14.4% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$90.35M— QoQ
Last fiscal yearDec 2025
$95.82M-13.5% YoY
Total Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-13.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Non-current Assets history

USD · from the balance sheet

Latest · FY2025
95.82M USD
Year-over-year change
-13.5%
1-year CAGR
-13.5%

Total Non-current Assets vs competitors

How GENB compares with its peers on the latest reported figures

  • GENB's Mar 2026 total non-current assets of $90.35M is the 2nd highest of the 5 companies compared; the peer median is $42.32M.
  • Total non-current assets amounts to 14.4% of total assets for GENB, versus a peer median of 20.6%.
GENB Competitors Peer median
Total Non-current Assets for GENB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ABCLAbCellera Biologics Inc.Sep 2026$623.71M -5.6%+6.8%41.6%
GENBGenerate Biomedicines, Inc.Mar 2026$90.35M ——14.4%
ABSIAbsci CorporationMar 2026$63.62M -16.8%-20.8%32.5%
STROSutro Biopharma, Inc.Mar 2026$21.02M -38.2%-24.8%8.7%
INBXInhibrx Biosciences, Inc.Mar 2026$12.63M -34.4%+9.5%6.9%
Peer median (excluding GENB) $42.32M-25.6%-7.0%20.6%

Competitors are the stored peer set for GENB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD

Generate Biomedicines, Inc.

NASDAQ:GENB

Intrinsic Alpha fair value

Locked

Current Price

$10.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.